-
Innovation Ranking
NewInnovation Ranking – BIO-key International Inc
BIO-key International Inc (BIO-key International) is a Software company. It carries out the development and marketing of fingerprint identification biometric technology and related security software solutions. It develops and markets fingerprint biometric identification and identity verification technologies, cryptographic authentication transaction security technologies and related identity management and credentialing software solutions. The company is also involved in developing automated finger identification technology that supplements or compliments other methods of identification and verification such as personal inspection identification, passwords, tokens, smart cards,...
-
Innovation Ranking
NewInnovation Ranking – Shanghai Kehua Bio-engineering Co Ltd
Shanghai Kehua Bio-engineering Co Ltd (KHB) is a medical device company that develops, manufactures and markets in vitro diagnostic devices and related products. The company’s product portfolio includes COVID-19 products, immunologic diagnosis, biochemical diagnosis, molecular diagnosis and POCT (point-of-care testing) products. It also offers comprehensive services for regional medical communities. KHB established R&D centers and production bases in many countries and regions including Italy. The company has sales support facilities in major cities in China and markets products in China...
-
Innovation Ranking
NewInnovation Ranking – BrightGene Bio-Medical Technology Co Ltd
BrightGene Bio-Medical Technology Co Ltd (BrightGene) is a biopharmaceutical company that manufacturing, research and develop of generic drugs. The company’s pipeline products include posaconazole, oseltamivir phosphate, orivancin, fidaxomycin, agatroban, fondaparinux, acarbose, iron supplements, trabectidine, pemetrexed disodium intermediate, eribulin mesylate, midotolin, everolimus and pimecrolimus, among others. Its veterinary drugs includes seramectin, telavancin hydrochloride, emodes, doramectin and dalbavancin. The company develops products in the therapeutic areas of cardiology, oncology, antibacterial, antifungal and veterinary. BrightGene is headquartered in Suzhou, Jiangsu, China.
-
Innovation Ranking
NewInnovation Ranking – Tianjin Ringpu Bio-Technology Co Ltd
Tianjin Ringpu Bio-Technology Co Ltd (Tianjin Ringpu) is a pharmaceutical and healthcare, service provider. The company carries out the production and sale of veterinary pharmaceuticals, vaccines and feed additives. It offers various varieties of animal health products for poultry, swine, ruminants, companion animals and aquatic, including chemical drugs, animal biological products, feed additives and herb extracts to veterinarians, animal raisers, farmers and governments. Tianjin Ringpu offers manufacture and sales of poultry vaccines, veterinary use vaccines, biological products for treatment, diagnostic...
-
Innovation Ranking
NewInnovation Ranking – Shenzhen Mindray Bio-Medical Electronics Co Ltd
Shenzhen Mindray Bio-Medical Electronics Co Ltd (Mindray) develops, manufactures and markets medical devices and solutions. The company offers in-vitro diagnostics, products for patient monitoring and life support, orthopedics, veterinary, and medical imaging systems, among others. Its major products include patient monitoring systems, anesthesia machines, ventilators, electrocardiographs, defibrillators, surgical lights, operating tables, medical supply units, infusion pumps endoscopes, and accessories. Mindray also offers a chemistry analyzer and reagents, flow cytometry, and mobile and digital radiography systems. The company serves hospitals, medical...
-
Product Insights
NewNet Present Value Model: Passage Bio Inc’s PBGM-01
Empower your strategies with our Net Present Value Model: Passage Bio Inc's PBGM-01 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: Passage Bio Inc’s PBFT-02
Empower your strategies with our Net Present Value Model: Passage Bio Inc's PBFT-02 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: Adicet Bio Inc’s ADI-001
Empower your strategies with our Net Present Value Model: Adicet Bio Inc's ADI-001 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: Nuvation Bio Inc’s NUV-868
Empower your strategies with our Net Present Value Model: Nuvation Bio Inc's NUV-868 report and make more profitable business decisions.Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: Gritstone Bio Inc’s GRANITE-001
Empower your strategies with our Net Present Value Model: Gritstone Bio Inc's GRANITE-001 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.